Board Meeting7 Aug 2026, 02:58 pm
Medicamen Biotech Board Meeting on Aug 14 to Approve Q1 FY27 Results
AI Summary
Medicamen Biotech Ltd has announced a Board of Directors meeting scheduled for August 14, 2026. The primary agenda is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Additionally, the board will review the Draft Annual Report and Draft Cost Audit Report for the financial year 2025-26. The trading window for designated persons will remain closed from July 1, 2026, until 48 hours after the financial results are declared.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- To approve Unaudited Financial Results for Q1 FY27.
- Draft Annual Report and Cost Audit Report for FY26 to be considered.
- Trading window closure in effect for designated persons.
Price Impact
More from MEDICAMEQ